OBJECTIVE: To assess the ability of the morphometric prognostic index (MPI) in predicting clinical outcome in a group of breast cancer patients with short-term follow-up and to assess the relationship between MPI and other prognosticators. STUDY DESIGN: The study group consisted of 63 cases of breast cancer. Follow-up data were available for 48 patients. MPI values were calculated, and degree of nuclear and tubular differentiation was investigated in each tumor. S-phase fraction (SPF), estrogen and progesterone receptors were also studied. RESULTS: The group of patients with MPI values < 0.60 had percent values of disease-free survival significantly higher than did those with MPI values > or = 0.60. Furthermore, significant direct correlations were found between MPI and degree of nuclear atypia and between MPI and SPF. Significant inverse relationships were found between MPI and tumor progesterone receptor levels and between MPI and degree of histologic tubular differentiation. CONCLUSION: The validity of MPI as a prognosticator in breast cancer was confirmed, even in a limited number of patients observed in short-term follow-up. MPI seems to be a reliable and economical prognosticator in selecting breast cancer patients for adjuvant chemotherapy.

Carbone, A., Serra, F. G., Rinelli, A., Terribile, D. A., Valentini, M., Bellantone, R. D. A., Rossi, S., Ausili Cefaro, G., Nardone, L., Piantelli, M., Capelli, A., Ranelletti, F. O., Morphometric prognostic index in breast cancer., <<Anal Quant Cytol Histol.>>, 1999; 21 (3): 250-254 [http://hdl.handle.net/10807/39391]

Morphometric prognostic index in breast cancer.

Carbone, Arnaldo;Rinelli, Alessandro;Terribile, Daniela Andreina;Bellantone, Rocco Domenico Alfonso;Nardone, Luigia;Capelli, Arnaldo;Ranelletti, Franco Oreste
1999

Abstract

OBJECTIVE: To assess the ability of the morphometric prognostic index (MPI) in predicting clinical outcome in a group of breast cancer patients with short-term follow-up and to assess the relationship between MPI and other prognosticators. STUDY DESIGN: The study group consisted of 63 cases of breast cancer. Follow-up data were available for 48 patients. MPI values were calculated, and degree of nuclear and tubular differentiation was investigated in each tumor. S-phase fraction (SPF), estrogen and progesterone receptors were also studied. RESULTS: The group of patients with MPI values < 0.60 had percent values of disease-free survival significantly higher than did those with MPI values > or = 0.60. Furthermore, significant direct correlations were found between MPI and degree of nuclear atypia and between MPI and SPF. Significant inverse relationships were found between MPI and tumor progesterone receptor levels and between MPI and degree of histologic tubular differentiation. CONCLUSION: The validity of MPI as a prognosticator in breast cancer was confirmed, even in a limited number of patients observed in short-term follow-up. MPI seems to be a reliable and economical prognosticator in selecting breast cancer patients for adjuvant chemotherapy.
Inglese
Carbone, A., Serra, F. G., Rinelli, A., Terribile, D. A., Valentini, M., Bellantone, R. D. A., Rossi, S., Ausili Cefaro, G., Nardone, L., Piantelli, M., Capelli, A., Ranelletti, F. O., Morphometric prognostic index in breast cancer., <<Anal Quant Cytol Histol.>>, 1999; 21 (3): 250-254 [http://hdl.handle.net/10807/39391]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/39391
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact